Nasdaq bcrx

BioCryst Pharmaceuticals, Inc. About the company. It is also developing BCX, an oral factor D inhibitor for complement-mediated diseases.

Key events shows relevant news articles on days with large price movements. Ardelyx Inc. ARDX 2. Amarin Corporation plc. AMRN 1. TG Therapeutics Inc common stock. TGTX 1.

Nasdaq bcrx

See all ideas. See all brokers. EN Get started. Market closed Market closed. No trades. BCRX chart. Today 0. Key stats. Market capitalization. Dividend yield indicated. Price to earnings Ratio TTM. Net income.

Net income. Net change in cash. Strategic Minerals optimistic as copper price rises 07 Mar.

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping us understand which sections of the website you find most interesting and useful. See our Cookie Policy for more information. These cookies are used to deliver our website and content. Strictly necessary cookies relate to our hosting environment, and functional cookies are used to facilitate social logins, social sharing and rich-media content embeds. Advertising Cookies collect information about your browsing habits such as the pages you visit and links you follow. These audience insights are used to make our website more relevant.

Key events shows relevant news articles on days with large price movements. Ardelyx Inc. ARDX 5. Amarin Corporation plc. AMRN 2. TG Therapeutics Inc common stock. TGTX 1. Aurinia Pharmaceuticals Inc.

Nasdaq bcrx

See all ideas. See all brokers. EN Get started.

Melanie martinez dancing

BioCryst is a biotechnology company that designs, optimizes and develops novel drugs that block enzymes involved in cancer, viral infections and autoimmune diseases. Second quarter earnings: EPS and revenues exceed analyst expectations Aug Spectral AI technology to revolutionise triage and treatment 07 Mar. Jon P. Future Growth. Consensus forecasts updated Feb Discover more. Provides Earnings Guidance for the Year Feb ARWR 3. Operating expense. First quarter earnings: EPS exceeds analyst expectations while revenues lag behind May Debt level and coverage. Announces Executive Changes Jul I propose that there will be no further rejection from.

.

About the company. Spectral AI technology to revolutionise triage and treatment 07 Mar. See all news matching. Is BCRX's price volatile compared to industry and market? Montgomery in and is headquartered in Durham, NC. Trading at good value compared to peers and industry. To do this, you need to open an account and follow a broker's procedures, then start trading. Beta 1Y. Price to earnings Ratio TTM. See other stocks reaching their highest and lowest prices. BioCryst Pharmaceuticals promotes Sheridan to development chief Sep Interactive Brokers. Amarin Corporation plc. See Fair Value and valuation analysis.